Evidence map›Paper›PMID 33083492›Full record

ArticleBioMed research international2020

Lack of PPAR

Bo Shen, Aimin Li, Yu-Jui Yvonne Wan, Guijia Shen, Jinshui Zhu, Yuqiang Nie

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Bo ShenDepartment of Gastroenterology, Shanghai Jiao Tong University Affiliated Shanghai Sixth Hospital, Shanghai, China.ORCID https://orcid.org/0000-0001-6033-3980
Aimin LiGuangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yu-Jui Yvonne WanDepartment of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA, USA.
Guijia ShenDepartment of Gastroenterology and Hepatology, The Affiliated Hospital of Jiujiang, Jiangxi, China.
Jinshui ZhuDepartment of Gastroenterology, Shanghai Jiao Tong University Affiliated Shanghai Sixth Hospital, Shanghai, China.ORCID https://orcid.org/0000-0002-8646-0176
Yuqiang NieDepartment of Gastroenterology and Hepatology, Guangzhou First Municipal People's Hospital, Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0001-5713-9642
Shanghai Jiao Tong University · CNGuangzhou First People's Hospital · CNJiujiang University · CNNanfang Hospital · CNUniversity of California, Davis · US

Funding

Liver Cancer Therapy by MiR-22 and Its InducersR01CA222490 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WAN, YU-JUI YVONNE · 2018 to 2023
$2.1M
NCI NIH HHS R01 CA222490
6 · The paper itself

Abstract

objectiveThe present study examined the role of PPAR

methodsThe effect of PPAR

resultsPPAR

conclusionsDue to the known tumor-promoting effect of SGK1, the present data suggest that PPAR

Indexed as

Liver NeoplasmsAnimalsApoptosisCarcinogenesisCell MovementCell ProliferationGene Expression Regulation, NeoplasticHep G2 CellsHumansImmediate-Early ProteinsMaleMiceMice, Inbred C57BLMice, KnockoutPPAR-betaPPAR deltaImmediate-Early ProteinsPPAR-betaPPAR deltaProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated Kinases

Identifiers

PMID33083492
PMCPMC7556072
OpenAlexW3092028066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.